Lesson plan

Tafrodol

Tafrodol was the brand name of a combination drug composed of the opioid analgesic drug tapentadol and the muscle relaxant and sedative drug carisoprodol within the same pill. It was manufactured by an Indian pharmaceutical company Aveo Pharmaceuticals and marketed primarily to consumers in West African countries such as Ghana, Nigeria and Cote d'Ivoire, from around 2018-2025 before being withdrawn from the market following safety concerns and issues with abuse. In contrast to comparable combination drugs such as dexamyl and desbutal which were marketed for legitimate medical applications but later withdrawn, tafrodol was never approved as an analgesic and appears to have been marketed primarily for recreational use, but under the guise of a legitimate pharmaceutical product taking advantage of weak regulatory laws in the destination markets. This ultimately led to both the banning of the product in both India and various West African nations, as well as Aveo Pharmaceuticals losing its license to manufacture pharmaceuticals within India.

Back to article

Article summary

Tafrodol was the brand name of a combination drug composed of the opioid analgesic drug tapentadol and the muscle relaxant and sedative drug carisoprodol within the same pill. It was manufactured by an Indian pharmaceutical company Aveo Pharmaceuticals and marketed primarily to consumers in West African countries such as Ghana, Nigeria and Cote d'Ivoire, from around 2018-2025 before being withdrawn from the market following safety concerns and issues with abuse. In contrast to comparable combination drugs such as dexamyl and desbutal which were marketed for legitimate medical applications but later withdrawn, tafrodol was never approved as an analgesic and appears to have been marketed primarily for recreational use, but under the guise of a legitimate pharmaceutical product taking advantage of weak regulatory laws in the destination markets. This ultimately led to both the banning of the product in both India and various West African nations, as well as Aveo Pharmaceuticals losing its license to manufacture pharmaceuticals within India.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.